Skip to main content
Equibles

GLENVIEW CAPITAL MANAGEMENT, LLC

Position in DHR — Danaher Corp /De/

CIK 1138995 NEW YORK, NY
Back to DHR Full portfolio

Position in DHR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$218,286,079
+$188,656,339 QoQ
Shares Held
1,145,979
+633.3% QoQ
Ownership
0.163%
of shares outstanding
% of Portfolio
4.36%
of 13F equity value
Holder Rank
#80
of 2,109 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DHR Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

GLENVIEW CAPITAL MANAGEMENT, LLC holds $794,373,256 across 3 Diagnostics & Research names. DHR ranks #3 (27.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 627,240 $314,473,046
2 A
Agilent Technologies, Inc.
 1,969,541 $261,614,131
3 DHR
Danaher Corp /De/
This page 		1,145,979 $218,286,079

All Filings in DHR

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $218,286,079 1,145,979
2026-03-31 $29,629,740 156,275
2025-12-31 $45,827,723 200,191
2025-09-30 $52,423,512 264,418
2025-06-30 $9,877,000 50,000